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Abstract
Nonenveloped viruses are generally released by the timely lysis of the host cell by a poorly understood process. For the
nonenveloped virus SV40, virions assemble in the nucleus and then must be released from the host cell without being
encapsulated by cellular membranes. This process appears to involve the well-controlled insertion of viral proteins into host
cellular membranes rendering them permeable to large molecules. VP4 is a newly identified SV40 gene product that is
expressed at late times during the viral life cycle that corresponds to the time of cell lysis. To investigate the role of this late
expressed protein in viral release, water-soluble VP4 was expressed and purified as a GST fusion protein from bacteria.
Purified VP4 was found to efficiently bind biological membranes and support their disruption. VP4 perforated membranes
by directly interacting with the membrane bilayer as demonstrated by flotation assays and the release of fluorescent
markers encapsulated into large unilamellar vesicles or liposomes. The central hydrophobic domain of VP4 was essential for
membrane binding and disruption. VP4 displayed a preference for membranes comprised of lipids that replicated the
composition of the plasma membranes over that of nuclear membranes. Phosphatidylethanolamine, a lipid found at high
levels in bacterial membranes, was inhibitory against the membrane perforation activity of VP4. The disruption of
membranes by VP4 involved the formation of pores of ,3 nm inner diameter in mammalian cells including permissive SV40
host cells. Altogether, these results support a central role of VP4 acting as a viroporin in the perforation of cellular
membranes to trigger SV40 viral release.
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Introduction
The virus life cycle is comprised of a number of consecutive,
discrete, and tightly regulated steps. These steps include binding,
internalization, penetration, replication, assembly, and release. The
final step of the viral life cycle involves the exit of viral progeny from
the cell to support virus dissemination for infection. Most enveloped
virions are released from the cell by a budding or a membrane
fission reaction with the virus acquiring a membrane coat during
this process [1,2]. Nonenveloped viral release generally requires cell
lysis after the viral multiplication cycle has been completed [3,4].
While this is a critical fundamental event in the viral life cycle, the
mechanism of nonenveloped viral release is weakly defined.
The timing of the nonenveloped virus exit step is critical for an
optimal life cycle, as lysis should occur immediately after an
adequate number of virus particles have been assembled. This lytic
event is associated with the disruption of cellular membranes,
which leads to cell death. However, a cytolytic pathway that avoids
apoptosis would also be advantageous, as this would ensure that
the virus is not encapsulated by apoptotic membrane blebs, which
would inhibit binding to host cell membranes.
Simian Vacuolating virus 40 (SV40) is a member of the
polyomavirus family. SV40 was the first eukaryotic virus
sequenced over thirty years ago [5,6] and studies of SV40 have
advanced our understanding of nuclear transport, transcriptional
regulation, and cell transformation [7]. Therefore, it serves as an
excellent paradigmatic virus to help expand our knowledge of the
undefined stages of the nonenveloped viral life cycle including viral
release. Three structural late proteins are found in the viral
particle: VP1, VP2 and VP3. VP1 forms 72-pentameric
capsomeres to create the viral capsid. Each capsomere contains
a single copy of either minor structural protein VP2 or VP3 in its
central cavity [8]. The same transcript encodes VP2 and VP3 with
translation initiation occurring from sequential Met residues to
create N-terminal truncations of each other. We recently
discovered that another downstream Met in the VP2/VP3
transcript also acted as a translation initiation site to encode an
additional protein termed VP4 [9]. VP4 is a 125 amino acid
protein with a central hydrophobic domain (Figure 1A). As the
synthesis of VP4 coincided with the time of viral-mediated cell
lysis, VP4 was proposed to play a role in viral release.
In this study, we have investigated the ability of VP4 to bind and
disrupt lipid membranes. For this purpose, a tagged version of
VP4 was constructed and its properties of membrane binding and
disruption were analyzed. These studies showed that VP4
efficiently bound red blood cell (RBC) membranes and supported
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addition, VP4 also disrupted liposomes mimicking the composition
of mammalian plasma and nuclear membranes. Deleting or
substituting the hydrophobic domain of VP4 drastically abolished
its membrane disruptive activity, indicative of a role for the
hydrophobic domain in membrane lysis. VP4 formed small
,3 nm diameter pores in mammalian membranes. Altogether,
these results support a central role for VP4 in the direct disruption
of cellular membranes to trigger SV40 viral release.
Results
Bacterial expression and purification of VP4
To obtain recombinant SV40 VP4 for analysis of its activity,
initially VP4 containing a C-terminal His tag was expressed in
Escherichia coli. His tagged VP4 was undetected after 12 hr of
induction (data not shown). The SV40 late protein VP4 contains a
19 amino acid central hydrophobic domain as suggested by
hydrophobicity analysis (Figure 1A). The hydrophobic nature of
VP4 combined with its potential lytic activity pose challenges for
its stable bacterial expression, and its purification as a water-
soluble and active protein [9].
The fusion of water-soluble proteins to the N-terminus of
aggregation-prone polypeptides is an efficient and effective
approach to maintain the solubility of a protein suitable for
bacterial expression [10]. The addition of a bulky soluble protein
such as glutathione S-transferase (GST) might diminish potential
lethal properties of VP4 that contribute to its inability to be
expressed in E. coli. To test if this strategy would support bacterial
VP4 expression, a construct of VP4 with an N-terminal GST tag
and a C-terminal His tag (GST-VP4, Figure 1A) was generated
and its bacterial expression was analyzed.
The GST-VP4 construct was effectively expressed in E. coli after
induction, however, the protein accumulated in the insoluble
protein fraction indicative of its appearance in intracellular
inclusion bodies (data not shown). Bacteria sequester insoluble
proteins into intracellular inclusion bodies to maintain cellular
homeostasis [11]. Since proteins found in inclusion bodies are
commonly misfolded and therefore likely inactive, strategies for
optimizing the production of soluble GST-VP4 were explored.
Osmolytes such as proline can be used to stabilize proteins in cells
[12,13]. The addition of proline (20 mM) and high concentrations
of salt (NaCl 300 mM) to the medium followed by growth at the
reduced temperature of 30uC significantly increased the solubility of
GST-VP4 (Figure 1B, lanes 3 and 4). High concentrations of salt in
the culture media induce E. coli to concentrate proline in vivo and
decreasethe tendencyofsomeproteinstoaggregate[14].GST-VP4
from the soluble fraction was purified to homogeneity utilizing
sequential interactions with its dual affinity tags (Figure 1C, lane 6).
Size-exclusion chromatography demonstrated that GST-VP4 was
monomeric (Figure S1). The cleavage of GST from VP4 with TEV
protease produced the two corresponding proteins GST and VP4
(Figure 1C, lane 7). However, the release of GST from VP4 led to
the aggregation of VP4. Therefore, purified uncleaved GST-VP4
was employed for all subsequent studies.
VP4 possesses hemolytic activity
To determine whether VP4 displays membrane disruptive
activity, a hemolysis assay was employed using bovine RBCs.
RBCs constitute a simple and efficient model system to study
protein-membrane interactions and lysis. RBCs were treated with
various concentrations of purified GST-VP4 at 37uC for 30 min.
The level of hemolysis was measured by determining the fraction
of hemoglobin released into the supernatant after centrifugation.
GST-VP4 mediated hemolysis was found to be concentration
dependent. GST-VP4 efficiently lysed bovine RBCs in a
concentration dependent manner inducing 50% lysis at a
concentration of 5 mg/ml (Figure 2A). The equilibrium value of
percent hemolysis showed sigmoidal dependence on GST-VP4
concentration, which is a characteristic feature of a process
dependent on self-oligomerization [15]. Maximum hemolysis was
observed with concentrations of 10 mg/ml of GST-VP4 or higher.
To determine the temperature dependency of hemolysis, time
courses for hemolysis were studied at different temperatures using
10 mg/ml of GST-VP4. Aliquots were removed at the indicated times
and percent hemolysis was determined. GST-VP4 rapidly and
efficiently lysed the RBCs at 37uC (Figure 2B). The maximal level
of hemoglobin was released after 10 min of treatment at 37uC. At the
lower temperatures, hemolysis occurred after a lag phase of 5 to
15 min. This lag phase period increased as the temperature was
reduced. In addition, the maximal level of hemolysis diminished as the
temperature was lowered. This suggests that the disruption of RBCs
by GST-VP4 involved a temperature dependent rate-limiting step.
The presence of metal ions and pH has been reported to influence
the hemolytic activity of viroporins and bacterial pore-forming toxins
[16,17]. To further analyze the hemolytic activity of VP4, the metal
ionic and pH dependency of the GST-VP4 mediated hemolytic
reactionwascharacterized. Hemolysiswasunaffected by the presence
of Cs
+,K
+ or Mg
2+ ions (Figure 2D). However, hemolytic activity
increased by 25% in the presence of Ca
2+.As biological levelsof Ca
2+
are regulated and vary over a large range from nM to mM [18], a
broader range of calcium concentrations were tested for their effect
on VP4 mediated hemolysis. Moderate increases in hemolysis were
observed in the presence of 5 mM or higher concentrations of Ca
2+
(Figure 2E). In addition, maximal hemolytic activity for GST-VP4
was observed at pH 7.2 (Figure 2C). The hemolytic activity of GST-
VP4 was dramatically reduced in acidic conditions and mildly
decreased in alkaline conditions. Altogether, GST-VP4 showed
optimal membrane disruption activity at 37uC in the presence of mM
calciumlevelsat neutralpH.Allstudiesthatfollowwereperformed at
the optimal temperature of 37uC and neutral pH.
Deletion of hydrophobic domain of VP4 impairs its ability
to bind and disrupt cellular membranes
Hydrophobic stretches of ,20 amino acids in length can
interact with membranes to form transmembrane segments [19].
Author Summary
Viruses exploit host cells for their propagation. Once an
adequate number of viral particles have been assembled
within the cell through the aid of cellular machinery of the
host cell, the virus must be released from the cell for the
virus to spread. For nonenveloped viruses or viruses that
are solely encapsulated by a protein shell, this step most
commonly involves the perforation of cellular membranes
resulting in the lysis or death of the host cell. The
mechanism for how this key terminal step in the viral life
cycle is performed is poorly understood. We demonstrated
that for the model nonenveloped virus SV40, the newly
discovered virally encoded protein, termed VP4, perforates
membranes by forming pores with a diameter of ,3n mi n
host cell membranes. While these pores are not of a
sufficient size to provide a conduit that permits the
movement of the virus through the membrane, they
support membrane destabilization that leads to the
disintegration of the membrane of the host cell and viral
release.
SV40 VP4 Is a Viroporin
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ability to perturb membranes, the hydrophobic domain was
deleted from GST-VP4 (GST-VP4DHD) and the membrane
disruptive activity of the deletion mutant was analyzed. GST-
VP4DHD was expressed and purified in the same way as GST-
VP4 (Figure 1B and C). Deletion of the hydrophobic domain
significantly reduced the membrane disruptive activity of VP4,
indicative of the hydrophobic domain playing a critical role in
plasma membrane lysis (Figure 3A). GST alone did not display
membrane disruptive activity, verifying that the late viral protein
VP4 possessed hemolytic or membrane disruption activity
(Figure 3A). Furthermore, hemolytic activity of VP4 was also
abolished when the hydrophobic domain was substituted with
either of two well-characterized transmembrane segments from
bacterial leader peptidase [20,21], demonstrating that the
hydrophobic domain of VP4 is specifically required for its lytic
activity (Figure S2A and Text S1).
A cell-binding assay was employed to determine if VP4 interacts
with cell membranes. GST-VP4, GST- VP4DHD and GST were
separately incubated without and with RBCs for 30 min at 37uC,
and bound and unbound fractions were separated by centrifuga-
tion. Cell binding was determined by the amount of protein that
sedimented with the cells. In the absence of RBCs, all of the
proteins tested remained soluble and were therefore found in the
supernatant (Figure 3B, lanes 2 and 3). However, in the presence
of RBCs, only GST-VP4 was localized to the RBC pellet,
indicative of the efficient binding of VP4 to RBCs (Figure 3B, lane
6). Both GST- VP4DHD and GST remained in the supernatant
after centrifugation demonstrating the necessity for the hydropho-
bic domain of VP4 for cell binding.
To determine if the bound protein was integrated into the lipid
bilayer of the cells, the bound fractions were alkaline extracted
with membrane and soluble fractions separated by ultracentrifu-
gation [22]. After alkaline extraction, the abundant RBC
membrane protein, anion exchanger 1 (AE1), was found in the
membrane pellet (Figure 3C, lane 5) [23]. Interestingly, the vast
majority of the membrane associated GST-VP4 (88%) was found
in the supernatant after alkaline extraction and centrifugation
(Figure 3B, lane 7 compared to 8). This suggested that GST-VP4
was not fully integrated into the lipid bilayer.
RBC proteins are not required for VP4-mediated
hemolysis
We next investigated if GST-VP4 required RBC membrane
proteins for its hemolytic activity. To remove extracellular-
exposed RBC proteins that could potentially serve as a platform
for VP4 binding, RBCs were treated with both proteinase K and
trypsin to generate protease-treated RBCs (pRBC). Membrane
fractions from treated and untreated RBCs after hypotonic lysis to
remove intracellular proteins were isolated by centrifugation. The
protein content of the membrane fractions was monitored by SDS-
PAGE. Numerous proteins corresponding to a wide range of sizes
were observed in the untreated sample, but proteins were absent
from the protease treated sample demonstrating the effectiveness
of the protease treatment (Figure 4A). Protease treatment of RBCs
or the removal of the surface proteins did not affect the GST-VP4
mediated hemolysis reaction (Figure 4B). Surface proteins were
not required for the membrane disruptive activity of GST-VP4.
This suggested that GST-VP4 interacted with the plasma
membranes of the RBCs directly via the lipids.
VP4 permeabilized liposomal membranes
To verify that VP4 acts on lipids directly, a membrane
disruption assay was employed that utilized liposomes with lipid
compositions representative of various biological membrane
sources. This fluorescence-based spectroscopic assay detected the
release of liposome-encapsulated fluorophores following the
addition of GST-VP4. Bathing the liposomes in quenchers of
the encapsulated fluorophore supports a reduction of fluorescence
intensity if the fluorophore is released from the liposomes or the
quencher is allowed to enter the liposome as a result of membrane
disruption permitting contact between the quencher and the
fluorophore (Figure 5A). In contrast, quenching is not observed if
the membrane remains intact and the quencher and the
fluorophore are unable to cross the membrane bilayer [24]. This
experimental system provides a highly tractable approach to
characterize the membrane disruption properties of VP4.
Large unilamellar vesicles (LUV) mimicking the lipid compo-
sitions of bacterial, and mammalian plasma and nuclear
membranes were prepared to examine the membrane disruption
activity of GST-VP4 (Table 1) [25,26,27]. GST-VP4 efficiently
disrupted mammalian plasma (PM-like) and nuclear membrane-
like (NuM-like) liposomes (Figure 5B). The activity against PM-like
liposomes was approximately double that which was directed
against NuM-like liposomes. The viral protein did not affect
liposomes mimicking the lipid composition of the bacterial inner
membrane (BcM-like). Furthermore, regardless of the liposomes
tested, the hydrophobic domain was found to be essential for the
membrane disruption activity of VP4, as VP4DHD and GST
alone displayed no significant membrane disruption. These results
demonstrated that VP4 possessed membrane-permeabilizing
activity that required its hydrophobic domain and its activity
was optimal against membranes that represented the lipid
composition of the mammalian plasma membrane.
To explore if the differences observed for liposome disruption
were caused by the ability of VP4 to bind to the various
membranes, a membrane-binding assay was employed. A
liposome flotation assay was used to isolate liposomes and monitor
VP4 binding. Bound and unbound fractions of VP4 were
quantified by immunoblotting. VP4 bound efficiently to both
PM-like and NuM-like liposomes and did not display any
association with BcM-like liposomes (Figure 5C, lanes 6, 9 and
12). These results were consistent with the fluorescence-based
liposome disruption assay. In addition, VP4DHD mutant and
GST did not bind any of the liposomal membranes (Figure 5C).
Therefore, the liposome binding results indicate that the
membrane disruption activity required stable membrane binding.
To investigate the origin for the difference in the activities of
VP4 to the various membranes, liposomes comprised of different
lipid compositions were tested to determine which lipids affected
the membrane disruption properties of VP4. VP4 was most active
against PM-like liposomes, followed by NuM-like liposomes, while
Figure 1. Bacterial expression and purification of VP4. (A) Schematic representation of the VP4 construct containing N-terminal GST and C-
terminal 6xHis tags. VP4 contains a hydrophobic domain (HD) with sequence designated. The hydrophobicity plot of VP4 using Membrane Protein
Explorer version 3 [46] is displayed. (B) Influence of the osmolyte, proline, on the solubility of GST-VP4 and GST-VP4DHD expressed in bacteria before
(2) and after (+) induction with IPTG. Total (T), supernatant (S), pellet (P) fractions were resolved by SDS-PAGE and visualized by coomassie brilliant
blue staining. Soluble GST-VP4 and GST-VP4DHD are designated by asterisks. (C) SDS-PAGE analysis of two-step affinity purification of GST-VP4 and
GST-VP4DHD.
doi:10.1371/journal.ppat.1002116.g001
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PLoS Pathogens | www.plospathogens.org 4 June 2011 | Volume 7 | Issue 6 | e1002116Figure 2. VP4 possesses hemolytic activity. (A) Percent hemolysis of bovine RBCs as a function of GST-VP4 concentration. RBCs (0.5%, v/v) were
incubated with various concentrations of the protein for 30 min at 37uC. (B) Kinetics of hemolysis of bovine RBCs as a function of temperature as
indicated. RBCs were incubated at different temperatures with GST-VP4 (10 mg/ml) for 30 min. (C) Hemolysis as a function of pH. Hemolysis reactions
were carried out at varying pH. Data are normalized with respect to samples containing only buffer and RBCs (0%), and containing RBCs with 50%
water to mediate complete lysis (100%). (D) Hemolysis in presence of different metal ions. Purified GST-VP4 was mixed with bovine RBCs. Reactions
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BcM-like liposomes were rich in phosphatidylethanolamine (PE)
and contained no cholesterol, the influence of PE and cholesterol
on the activity of VP4 was tested. Given that VP4 supported 50%
fluorescence quenching in NuM-like liposomes, the composition of
these liposomes was modified in an attempt to optimize membrane
disruption by VP4.
VP4-mediated membrane disruption increased when PE was
excluded from the NuM-like liposomes (Figure 6A, NuM-like-
noPE). This suggested that PE might inhibit membrane pertur-
bation by VP4. The addition of cholesterol to the NuM-like
liposomes (NuM-like+Chol) caused a significant decrease in
membrane permeabilization. Cholesterol did not appear to
produce a direct inhibitory effect as no difference was observed
between the quenching of phosphatidylcholine (PC) liposomes and
cholesterol+PC-containing liposomes (Figure 6B, Chol+PC). VP4
showed highest activity against PM-like membranes that contained
50% cholesterol, again suggesting that cholesterol did not have a
direct inhibitory effect on VP4 activity (Figure 5B).
Increasing cholesterol levels in NuM-like liposomes was also
associated with a decrease in the levels of PC and sphingomyelin
(SM) (Table 1). Therefore, the level of SM and PE was varied
while keeping the cholesterol content constant. First, the addition
of PE to the cholesterol+PC liposomes produced a decrease in
quenching (Figure 6B), consistent with the previously discussed
inhibitory effect of PE. Interestingly, this inhibitory effect was
reversed by the addition of SM (Figure 6B). As VP4 efficiently
bound to all liposomes tested besides the bacterial-like liposomes
that were rich in PE (Figure 5C, 6C and 6D), high concentrations
of PE appeared to inhibit VP4 binding. Altogether these results
showed that VP4 permeabilizing activity was dependent on the
membrane lipid composition and VP4 was most active against
PM-like liposomes due to what appeared to be a combined effect
of lower PE and higher SM levels.
VP4 forms small size selective pores in biological
membranes
The observed release of liposomal content by VP4 led to the
question of whether VP4 lysed the liposomes by creating discrete
pores in the membrane or by a non-specific membrane
solubilization or a detergent-like effect. In support of the pore
formation hypothesis, LUVs average diameter or their total scatter
intensity did not change significantly after incubation with VP4
(Figure 5D, 5E and data not shown). This indicated that the
liposomes were not solubilized by the viral protein.
To further explore the characteristics of the pores formed by
VP4, the pore forming activity of VP4 on cellular membranes was
tested by analyzing the osmoprotection capabilities of different size
polyethylene glycols (PEGs). The rationale for this approach is that
pores at the plasma membrane produce cell lysis by uncontrolled
water and ion influx. PEGs can serve as osmotic protectants and
prevent water and ion influx, only if the PEG molecules are larger
than the size of the VP4 formed pore. In contrast, if PEGs are
small enough to pass through pores formed by VP4, their
concentration equilibrates rapidly across the membrane and no
osmotic protection is conferred, resulting in cell lysis. Therefore,
the presence of discrete-sized pores in the membrane and their
approximate diameter can be estimated by determining the
minimum size PEG that confers osmoprotection [28].
The hemolytic activity of GST-VP4 was examined in the
presence and absence of 30 mM PEGs. Smaller PEGs (1 and
4 kD) had negligible osmoprotection effect on hemolysis, whereas
PEGs of 6 kD and larger reduced hemolysis (Figure 7A). These
results supported the hypothesis that VP4 formed pores in RBC
membranes. A sharp transition in osmoprotection was observed
between PEGs of 4 and 6 kD with estimated hydrodynamic
diameters of 3.8 nm and 6.4 nm, respectively. This suggested that
VP4 formed ,4–6 nm diameter pores in the plasma membrane of
bovine RBCs.
The pore formation properties of VP4 were examined using Cos
7 cells, a SV40 permissive host cell line. Cell lysis can be followed
by the release of cytosolic proteins. After VP4 treatment, the
release of cytoplasmic lactate dehydrogenase (LDH) from Cos 7
cells was used to probe cell lysis. Incubation of Cos 7 cells at 37uC
for 30 min led to the complete release of intracellular LDH
(Figure 7B). Consistent with hemolysis and liposome disruption
results, the deletion of the hydrophobic domain of VP4 abolished
its cytolytic activity.
The cytolytic activity of VP4 on Cos 7 cells was analyzed using
different size PEGs. PEGs larger than 3.35 kD efficiently inhibited
cytolysis (Figure 7C). There was a gradual reduction in VP4-
mediated cytolysis in the presence of PEG from 1 to 2 kD in size.
These results suggested that VP4 formed smaller pores in the
plasma membrane of Cos 7 cells. The transition in osmoprotection
occurred with PEGs between 2 and 3.35 kD in size, which
corresponded to hydrodynamic diameters of 2.8 and 3.5 nm,
respectively. This indicated that VP4 formed pores of ,3n mi n
diameter in the cell membrane of the SV40 permissive host cells.
Discussion
VP4 is a late expressed SV40 hydrophobic protein proposed to
play a role in viral release [9]. Here, the membrane disruption
properties of purified VP4 were thoroughly characterized. VP4
efficiently bound and permeabilized bovine RBCs. The hydro-
phobic domain of VP4 was required for these activities, which
were optimal at 37uC and neutral pH in the presence of calcium.
The disruption of LUV by VP4 demonstrated that VP4 had a
preference for liposomes comprised of lipid compositions repre-
senting plasma and nuclear membranes. The membrane disrup-
tion activity of VP4 supported the formation of ,3 nm pores in
the plasma membranes of RBCs and the permissive SV40 host
(Cos 7 cells). These results are consistent with VP4 causing the lysis
of infected cells to support the poorly understood process of
nonenveloped viral release.
VP4 disrupted membranes by directly interacting with the
membrane lipid bilayer and its membrane disruption ability was
dependent upon the composition of the bilayer. VP4 efficiently
lysed bovine RBCs, which are rich in SM [29]. In liposome (or
LUV) studies, SM rescued VP4 activity in the presence of the
inhibitory lipid PE. Bacterial membranes contain high levels of PE.
The inability of GST-VP4 to lyse PE-rich or BcM-like liposomes
likely fortuitously contributed to the expression of large amounts of
the protein in bacteria. PE is a conical lipid that induces negative
membrane curvature, which might contribute to its inability to
support VP4 pore formation [30,31]. Pore formation by the
antimicrobial peptide from the Xenopus skin, magainin 2, was
induced by positive membrane curvature and inhibited by
negative membrane curvature [30]. The membrane disruption
were incubated in 10 mM Tris (pH 7.5)/150 mM NaCl containing Cs
+,K
+,M g
2+,C a
2+ ions. (E) Calcium concentrations were varied for the hemolytic
assay over a wider range. The error bars represent the standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1002116.g002
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whereas high levels of PC favored efficient pore formation. Both
nuclear and plasma membranes are rich in PC. While GST-VP4
disrupted liposomes that were representative of both plasma and
nuclear membranes, it displayed a strong preference for PM-like
liposomes. This was consistent with its ability to efficiently lyse
RBCs and Cos 7 cells. The membrane disruption activity of VP4
was highly influenced by the lipid composition of the LUV.
Enveloped and nonenveloped viruses utilize proteins termed
viroporins (viral-encoded membrane pores) to mediate membrane
disruption events during the viral life cycle. Currently over a dozen
viroporins are known and their functions appear to be similar to
the well-studied toxins from bacterial pathogens such as Bacillus
anthracis protective antigen (PA63) and E. coli (hemolysin) that form
membrane pores [32]. Typically, viroporins are small (60–120
residues), hydrophobic proteins that form oligomeric structures in
lipid bilayers of infected cells. These viral-encoded proteins form
hydrophilic pores in host cell membranes to modify their
permeability or stability. The membrane pores support the
movement of ions or small molecules across membrane bilayers,
to potentially aid in the viral entry and penetration steps, or
promote the efficient release of virions by compromising the
integrity of host cell membranes [33].
We demonstrated that VP4 acts as a viroporin. In vitro translated
VP4 efficiently bound to GST-VP4 suggestive of the ability of VP4
to oligomerize (Figure S2B), a property shared by viroporins.
Viroporins also frequently contain stretches of basic amino acids
that are proposed to act as detergents by potentially binding to
anionic lipid head groups [33]. VP4 possesses a basic pI of 10.2
and a large number of basic residues disproportionately clustered
to the C-terminal side of the hydrophobic domain. These basic
residues include a nuclear localization sequence, shared by both
VP2 and VP3. While the lipid composition and the hemolytic
activity of VP4 are consistent with its ability to associate with and
disrupt plasma membranes, it will be of interest to determine what
cellular membranes VP4 interacts with when it is expressed in the
cytoplasm of host cells, as is the case during viral infection.
Previous results found that VP4 appeared to accumulate at the
Figure 3. The hydrophobic domain of VP4 is required for its binding and disruption of RBC membranes. (A) GST-VP4 or GST-VP4DHD
were incubated with bovine RBCs for 30 min at 37uC. Released hemoglobin was measured by the A414 of the supernatant after centrifugation and the
removal of unlysed cells. GST was used as a control to rule out its contribution in the hemolytic activity of GST-VP4. (B) Hemolysis reaction mixtures
(lane 4, T) containing bovine RBCs and GST-VP4 or GST-VP4DHD were incubated at 37uC for 30 min. RBC bound (P, lane 6) and unbound (S, lane 5)
proteins were separated by centrifugation. Membrane fractions (lane 6) were alkaline extracted with 0.1 M Na2CO3, pH 11.5 and ultracentrifuged to
separate the soluble (S) and membrane (M) fractions (lane 7 and 8). Samples resolved by reducing SDS-PAGE were immunoblotted with antibody
against GST. Separate reactions were performed in the absence of RBCs (lanes 1–3). (C) Bovine RBCs were separated as in B and the SDS-PAGE gel was
stained with coomassie blue to visualize the abundant RBC membrane protein, anion exchanger 1 (AE1).
doi:10.1371/journal.ppat.1002116.g003
Figure 4. RBC surface proteins are not required for VP4-mediated hemolysis. (A) RBCs (lane 1) were pretreated with trypsin and proteinase
K (pRBCs, lane 2) to remove surface proteins. Membrane fractions after hypotonic lysis were resolved by reducing SDS-PAGE and proteins were
visualized by coomassie blue staining. (B) GST-VP4 was mixed with untreated or protease treated RBCs. After incubation for 30 min at 37uC,
hemoglobin release was measured by the A414 of the supernatant after centrifugation to remove unlysed cells. The error bars represent the standard
deviation from two independent experiments performed in triplicate.
doi:10.1371/journal.ppat.1002116.g004
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PLoS Pathogens | www.plospathogens.org 8 June 2011 | Volume 7 | Issue 6 | e1002116Figure 5. VP4 permeabilization of liposomes. (A) Scheme showing the liposome disruption assay employed. Membrane disruption was
examined by encapsulating [Tb(DPA)
3-
3] fluorophore into LUVs (large unilamellar vesicles). When these LUVs were resuspended in a solution
containing EDTA (quencher), protein mediated membrane disruption was monitored by the quenching of [Tb(DPA)
3-
3] emission as the encapsulated
molecules were released, and terbium ions were chelated by EDTA. (B) VP4 disrupts mammalian plasma (PM-like) and nuclear membrane-like (NuM-
like) LUVs. LUVs mimicking the lipid compositions of bacterial inner membrane (BcM-like), and mammalian plasma and nuclear membranes were
prepared to examine the membrane disruption activity of GST-VP4 and GST-VP4DHD. GST was used as a control. Mock LUVs were incubated in
absence of any protein. Liposome disruption was evaluated using LUVs prepared with selected lipid compositions, and the percentage of
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lacking VP2 and VP3 [9]. The directionality of the VP4
membrane binding and disruption in the hemolysis reaction
differs from that utilized during the viral life cycle. The plasma
membrane is asymmetric, possessing higher concentrations of
phosphatidylserine (PS) on the inner facing membrane leaflet.
Since PS did not affect VP4 pore forming activity, this membrane
asymmetry was not likely to affect the membrane permeabilization
assay. These results indicated that VP4 effectively disrupted
membranes that mimicked plasma and nuclear membrane
compositions, with a preference for plasma-like membranes.
The protein-mediated mechanisms for membrane lysis have
been studied extensively using antimicrobial peptides, which are
lytic substances secreted by cells for a means of defense against
microbial pathogens [34]. Antimicrobial peptides can contain
short cationic and hydrophobic sequences that lack Cys residues,
like VP4. Antimicrobial peptides have been proposed to disrupt
bacterial membranes using three possible mechanisms. First, the
barrel-stave model involves the formation of transmembrane pores
created by alpha-helices integrated into the bilayer. This
mechanism of membrane perturbation is unlikely for VP4 as
VP4 was extracted from membranes after alkaline treatment,
indicating that it was not fully integrated into the bilayer
(Figure 3B). Secondly, in the carpet model, peptides accumulate
on the membrane surface through electrostatic forces (cationic
proteins binding anionic lipid head groups). At high concentra-
tions, it is proposed that these peptides disrupt the membrane in a
detergent-like manner resulting in the formation of micelles. The
sharp size distribution in the pores formed by VP4 (Figure 7A and
C), and the invariable diameter of the LUVs observed by dynamic
light scattering (Figure 5D and E) after VP4 treatment are not
consistent with VP4 acting through a carpet model since complete
membrane disruption or lysis was not observed. Finally for the
toroidal-pore model, proteins insert into the membrane and by
interacting with the lipid head groups force curvatures in the
interacting lipids, resulting in the fusion of the inner and outer
leaflets at the lipid-protein interaction site. The toroidal-pore
model differs from the barrel-stave model in that the protein
interacts mostly with the lipid head groups and is not directly
inserted through the hydrophobic core of the membrane [35]. The
sharp pore size distribution and the ability to extract VP4 from
membranes after alkaline treatment are consistent with VP4
forming a toroidal-pore within the membrane. However, further
studies will be needed to fully delineate the membrane disruption
mechanism of VP4.
Cytolytic viruses such as the nonenveloped polyomaviruses and
picornaviruses release their viral progeny by initiating the timely
lysis of host cells. The release of viral particles by cell lysis after
adequate numbers of viral particles have been assembled ensures
the efficient spread of the virus. Previously, we identified SV40
VP4 as a protein encoded within the viral genome that is
expressed in the host cell at later times during infection that
coincide with viral release [9]. The SV40 virus has a diameter of
50 nm therefore it is too large to be directly translocated through
the ,3 nm VP4 pores formed in Cos 7 cells. Whereas GST-VP4
efficiently forms pores in mammalian cells, at this time we cannot
rule out the possibility that the size of the pore is influenced by the
GST attached to its N-terminus. However, we favor the
explanation that VP4 pores alter the cytoplasmic concentration
of ions or other small molecules, which leads to cell lysis. This
appears to be the mechanism for the 2B protein mediated release
of picornavirus [36]. Alternatively, VP4 may form heterocom-
plexes involving other viral proteins that influence the size of the
pores formed. Recently for JC virus (a human polyomavirus), the
viral encoded agnoprotein was identified as a viroporin that aids in
the release of JC virus [37]. As the SV40 genome also encodes for
the hydrophobic agnoprotein, it is possible that these proteins
work in concert to initiate viral release.
VP4 is an N-terminal truncation of the late structural viral
proteins VP2 and VP3 [9]. Our previous studies found that VP3
and VP4 co-expression supported bacterial lysis suggesting that
heterocomplexes between other late proteins and VP4 may
influence lipid specificity or the size of the pores formed. While
VP4 is solely found in infected cells [9], VP2 and VP3 are minor
structural components of the viral particle [5,6]. Upon internal-
ization, SV40 traffics to the endoplasmic reticulum, the proposed
site of uncoating and penetration [38–41]. An important issue for
the penetration of nonenveloped viruses is how does a subviral
particle or the viral genome cross endomembranes without
disrupting cellular homeostasis so that the cell can be exploited
for viral production for subsequent hours or days [42,43]. VP2 and
VP3 have been shown to insert into ER membranes [22]. This
leads to the provocative possibility that since VP2 and VP3 both
possess the VP4 sequence involved in membrane disruption, the
exposure of VP2 and VP3 after viral uncoating supports
membrane disruption to permit viral penetration. Interestingly,
VP2 and VP3 from SV40 and polyomavirus have been shown to
exhibit membrane disruption activities [44,45]. Future studies will
be required to address the properties of VP2/VP3 and VP4-
heterocomplexes, and their roles in viral penetration and release.
fluorophore quenched is indicated. Each data point shows the average of at least two independent measurements with error bars representing
standard deviations. (C) Flotation of proteins on sucrose gradients after incubation either without (-, lanes 1–3) or with PM-like (lanes 4–6), NuM-like
(lanes 7–9), or BcM-like (lanes 10–12) LUVs to separate unbound (U; lanes 2, 5, 8 and 11) and bound (B; lanes 3, 6, 9 and 12) fractions. Proteins were
resolved by SDS-PAGE and immunoblotting with anti-GST antibody. (D) Average diameter of PM-like LUVs before and after 30 min incubation with
the indicated proteins as determined by dynamic light scattering. Each data point shows the average of at least two independent measurements with
error bars representing standard deviation. (E) Average diameter of NuM-like LUVs determined similarly to D.
doi:10.1371/journal.ppat.1002116.g005
Table 1. Lipid composition of liposomes.
Liposomes Chol PC PE SM PS PG
Bacterial (E. coli) inner membrane (BcM-like) 0 0 80 0 0 20
Mammalian plasma membrane (PM-like) 50 20 11 13 6 0
Mammalian nuclear membrane (NuM-like) 15 51 20 9 5 0
NuM-like-noPE 19 64 0 11 6 0
NuM-like+Chol 50 31 12 5 3 0
PC 0 100 0 0 0 0
Chol+PC 40 60 0 0 0 0
Chol+PC+PE 40 40 20 0 0 0
Chol+PC+SM 40 45 0 15 0 0
Chol+PC+PE+SM 40 25 20 15 0 0
The lipid compositional data are expressed as a molar percentage of the total
lipid. PC, phosphatidylcholine; PE, phosphatidylethanolamine; SM,
sphingomyelin; PS, phosphatidylserine; PG, phosphatidylglycerol; Chol,
cholesterol.
doi:10.1371/journal.ppat.1002116.t001
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PLoS Pathogens | www.plospathogens.org 10 June 2011 | Volume 7 | Issue 6 | e1002116Figure 6. Activity of VP4 is dependent upon the lipid composition of the membranes. (A) Membrane disruptive activity of GST-VP4
measured as percentage fluorescence quenching with two sets of LUVs where phosphatidylethanolamine (PE) was excluded from NuM-like LUVs
(NuM-Iike-noPE) or the percentage of cholesterol was increased (NuM-Iike+Chol). Each data point shows the average of at least two independent
measurements and the error bars denote the standard deviation of the experiment. See Table 1 for lipid fractions. (B) Membrane disruptive activity of
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Reagents
The GST-Tag (12G8) mouse monoclonal antibody was
purchased from Abmart (Arlington, MA). CytoTox 96 cytotoxicity
assay kit for LDH release determination was purchased from
Promega (Madison, WI). All phospholipids were obtained from
Avanti Polar Lipids (Alabaster, AL), while cholesterol was obtained
from Steraloids (Newport, RI). AcTEV protease was purchased
from Invitrogen (Carlsbad, CA). All other reagents were purchased
from Sigma (St. Louis, MO).
DNA constructs
The pGEX-6P-1 plasmid (Amersham Bioscience; Piscataway,
NJ) was modified to include a tobacco etch virus (TEV) protease
site and a C-terminal 6xHis epitope upstream and downstream of
the multiple cloning site, respectively, to create pGEX-6P-1-TEV-
His. The GST-tagged version of full length VP4 was created by
PCR cloning into the bacterial expression plasmid pGEX-6P-1-
TEV-His using standard techniques. VP4 contained an N-
terminal GST tag and a C-terminal His tag (GST-TEV-VP4-
His). The QuikChange mutagenesis primer design program was
used to delete the hydrophobic domain of VP4 (amino acids 65–
83, PQWMLPLLLGLYGSVTSAL) to create VP4DHD. Muta-
genesis was confirmed by sequencing.
Recombinant protein expression and purification
The BL21 E. coli Rosetta strain (DE3: pLysS) (Novagen) was
transformed with GST-Tev-VP4-His and grown at 37uCt oa nO Do f
0.4 at 600 nm. NaCl (300 mM) was added to increase the osmolality
of the nutrient medium. Simultaneous with the osmotic increase, the
medium was supplied exogenously with 20 mM proline and the
culture was induced with 1 mM IPTG for 4 hr at 30uC. Cells were
centrifuged, resuspended in PBS (pH 7.4)/10 mM DTT with
200 mg/ml lysozyme and protease inhibitors, and rotated for 30 min
at 37uC. Triton X-100 (1%) was added to the cells, which were then
sonicated and the insoluble debris was sedimented by centrifugation
for 20 min at 12,0006g. The clarified supernatant was then added to
GST Sepharose 4B (Amersham Biosciences) matrix pre-equilibrated
with PBS (pH 7.4)/10 mM DTT/1% Triton X-100. The matrix was
washed three times with PBS (pH 7.4), and the protein was eluted with
freshly prepared 10 mM reduced glutathione (in 50 mM Tris-HCl,
pH 8.0). The eluate from GST Sepharose resin was further purified by
adding the eluate to Ni-NTA His Bind resin (Novagen) pre-
equilibrated with PBS (pH 7.4)/10 mM imidazole and additional
150 mM NaCl. The matrix was washed three times with PBS
(pH 7.4)/50 mM imidazole, and the protein was eluted with 250 mM
imidazole/PBS (pH 7.5). Protein purity was confirmed bySDS-PAGE
and protein concentration was determined using a Bradford assay
(Biorad). TheexpressionandpurificationofGST-TEV-VP4DHDand
GST-TEV-His were performed similarly.
Hemolysis assay
Bovine RBCs were washed repeatedly in cold PBS immediately
before use. Reactions (700 ml) were incubated at 37uCi nh e m o l y s i s
buffer (PBS, pH 7.4, 1 mM DTT and 200 ng BSA) with 0.5%
RBCs, without or with 30 mM PEG (Fluka) and 10 mg/ml VP4,
unless otherwise noted. Each time point for time course studies
represented a separate reaction. End-point samples were removed
after 30 min. Hemolysis was carried out in 10 mM Tris (pH 7.5)/
150 mM NaCl containing 1 mM DTT and 200 ng BSA when the
effect of ions was studied. Metal chlorides were added to the
hemolysis reaction buffer at a final concentration of 40 mM.
Reactions were centrifuged at 6,0006g for 5 min at 4uCt op e l l e t
unlysed cells. The absorbance of the supernatant was measured at
414 nm. Percentage of hemolysis was calculated as [(A414 (sample) 2
A414 (blank))/(A414 (water) 2 A414 (blank))]6100.The blank reaction
contained all components except protein and PEG. RBCs were
hypotonically lysed by adding 50% water. Protease-treated RBCs
were created by incubating cells at a concentration of 10% (v/v) in
10 mM Tris (pH 7.5)/150 mM NaCl, 20 mM MgCl2 containing
0.5 mg/mlproteinase K,0.5 mg/mltrypsin, and1.5 mMCaCl2 for
90 min at 37uC with gentle agitation. Proteases were inactivated
with 2 mMPMSFandthecells were washedtwice with cold10 mM
Tris (pH 7.5)/150 mM NaCl, 20 mM MgCl2 with 2 mM PMSF.
RBC binding and integration
For determining RBC cell surface binding, hemolysis was
carried out as described above at 37uC for 30 min. The cells were
then centrifuged at 6,0006g for 5 min and the supernatant and
pellet fractions were separated. Alkaline extractions were per-
formed by resuspending the cell pellet in 700 ml of ice-cold 0.1 M
Na2CO3 (pH 11.5), followed by a 30 min incubation on ice. The
solution was layered on top of a 100 ml sucrose cushion, and the
membrane-bound fraction was isolated by ultracentrifugation for
20 min at 65,0006 ga t4 uC. The membrane-bound pellet was
resuspended in sample buffer, and the supernatant containing the
peripherally associated proteins was TCA precipitated, washed
with acetone, and resuspended in sample buffer for SDS-PAGE
(13% acrylamide) and immunoblotting.
Liposome preparation
LUVs or liposomes were generated using a Liposofast extruder
(Avestin Inc., Ottawa, Canada) [24]. Chloroform solutions of lipids
[PC (POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine); PE
(POPE, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine);
PS (POPS, 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine);
PG (POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-(Phospho-rac-1-glyc-
erol); SM (sphingomyelin)] were mixed in the respective ratios and
chloroform was evaporated at 37uC with a mild N2 flow. The lipid
film waskept under vacuum forat least3 h to eliminatetracesof the
organic solvent. To hydrate the lipid mixture, 0.25 ml of Hepes
buffer saline (HBS, pH 7.5) was added to the dried phospholipid/
sterol mixture (final total lipid concentration 10 mM), and the
samples were incubated for 30 min at 37uC. The lipids were then
resuspended by vortexing. The suspended lipid mixtures were
frozeninliquid N2andthawedat37uCatotaloffivetimestoreduce
the number of multilamellar liposomes and to enhance the trapped
volumes of the vesicles [24]. Then the samples were passed at room
temperature21 times throughtheextruder equippedwith a 100 nm
pore size polycarbonate filter. The resulting liposomes were stored
at 4uC and used within 2 weeks of production. Liposomes
GST-VP4 with five different sets of LUVs: PC, Chol+PC, Chol+PC+PE, Chol+PC+PE+SM and Chol+PC+SM. Each data point shows the average of at least
two independent measurements and the error bars denote the standard deviation. (C) Flotation of proteins on sucrose gradients after incubation
either without (-, lanes 1–3) or with NuM-like-noPE (lanes 4–6), NuM-like (lanes 7–9), or NuM-like+Chol (lanes 10–12) LUVs to separate unbound (U;
lanes 2, 5, 8 and 11) and bound (B; lanes 3, 6, 9 and 12) fractions. Proteins were resolved by SDS-PAGE and immunoblotting with anti-GST antibody.
(D) Flotation of proteins on sucrose gradients after incubation with PC (lanes 1–3), Chol+PC (lanes 4–6), Chol+PC+PE (lanes 7–9), Chol+PC+PE+SM
(lanes 10–12), or Chol+PC+SM (lanes 13–15) LUVs. Proteins were resolved by SDS-PAGE and immunoblotting with anti-GST antibodies.
doi:10.1371/journal.ppat.1002116.g006
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[Tb(DPA)3
3-], were prepared as above, except that HBS buffer
included 3 mM TbCl3 (Alfa Aesar, WardHill, MA), and 9 mM2,6-
pyridinedicarboxylic acid (DPA, neutralized to pH 7). The resulting
liposomes were separated from non-encapsulated [Tb(DPA)3
3-]b y
gel filtration (Sepharose CL-6B-200, 0.7 cm inner diameter
650 cm) in HBS buffer.
Liposome permeabilization assay
Liposomes (100 mM total lipids) were suspended in 300 mlo f
buffer A (PBS, pH 7.4) containing 5 mM EDTA. The net initial
emission intensity (F0) was determined after equilibration of the
sample at 25uC for 5 min. Aliquots of 3 ml containingthe amount of
protein that gives the final concentration of 5 mg/ml were added
and the samples were incubated for 30 min at 37uC. After re-
equilibration at 25uC, the final net emission intensity (Ff) of the
sample was determined (i.e., after blank subtraction and dilution
correction) and the fraction of marker quenched was estimated
using (F0-Ff)/(F0-FT),whereFT isthenet emission intensityobtained
when the same liposomes are treated with 3 mM Triton X-100 (i.e.,
under conditions of maximal release of the fluorophore).
Steady state fluorescence spectroscopy
Intensity measurements were performed using the Fluorolog 3–
21 spectrofluorimeter equipped with a 450 W xenon arc lamp, a
double excitation monochromator, a single emission monochro-
mator, and a cooled PMT. The excitation wavelength/bandpass,
and the emission wavelength/bandpass were respectively: 278/2
and 544/4 nm for [Tb(DPA)3
3-]. For [Tb(DPA)3
3-] measurements,
a 385 nm longpass filter was placed in the emission light path to
block any second-order scatter emission light. Measurements were
done in 464 mm quartz microcells stirred with a 262m m
magnetic bar as described previously [24].
Liposome flotation assay
Binding reactions (75 ml) containing LUVs (400 mM) and protein
(the amount of protein added was such that the ratio of LUVs to
protein was same as that used in liposome permeabilization assay)
were incubated at 37uC for 30 min. LUVs-bound and unbound
proteins were separated by flotation through sucrose gradients, as
liposomes float in the gradient when a g-force is applied, while free
proteins sediment. Sucrose/HBS (225 ml of 67%) was added to the
bindingreactionsand thoroughlymixed.Thesamples wereoverlaid
with 360 ml of 40% sucrose, followed by 240 ml of 4% sucrose.
Centrifugation was carried out for 50 min at 90,0006 ga t4 uC.
Three 300 ml fractions (upper, middle, and bottom) were collected
from the gradient. After trichloroacetic acid precipitation and
resuspension in SDS sample buffer, samples were analyzed by SDS-
PAGE and immunoblotting.
Dynamic light scattering
The average size of the liposomes, before and after incubation
with VP4, was determined by dynamic light scattering. Measure-
ments were made at room temperature using a PDDLS Coolbatch
90T/PD2000DLS
Plus instrument (Precision Detectors, Inc.,
Franklin, MA) employing a 30-mW He-Ne laser source
(658 nm) and a photodiode detector at an angle of 90u. VP4
and liposome concentrations were the same as that employed for
the liposome permeabilization assays.
Lactate dehydrogenase (LDH) release
The assay was carried out by plating Cos 7 cells (10,000 cells/
well) and incubating the cells with 10 mg/ml protein for 30 min at
37uC. Aliquots of media (50 ml) were removed for the determi-
nation of LDH release. The CytoTox 96 cytotoxicity assay kit was
used to determine the level of LDH released from the cells
according to the manufacturer’s instructions. After allowing
30 min of incubation with substrate, the A490 was determined
using a BioTek Synergy 2 multi-mode microplate reader. As a
control for total cell-associated LDH, Cos 7 cells in selected wells
were lysed with 0.9% Triton X-100. Percentage LDH release was
calculated by dividing the A490 released from samples by total cell-
associated LDH release and multiplying by 100.
Accession number
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) ac-
cession number for SV40 VP4 is DAA06058.1.
Supporting Information
Figure S1 GST-VP4 size determination by SEC. (A) The
calibration plot for Superdex 200 10/30 GL column. Standard
proteins used were bovine thyroglobulin (669 kD); horse spleen
apoferritin (443 kD); sweet potato b-amylase (200 kD); yeast
alcohol dehydrogenase (150 kD); bovine serum albumin (66 kD);
ovalbumin (45 kD), and bovine carbonic anhydrase (29 kD). GST-
VP4 is indicated by a solid square. Vo (determined using blue
dextran) and Ve are the column void volume and the protein
elution volume, respectively. (B) Chromatogram of the elution of
purified GST-VP4 on the Superdex 200 10/30 GL column as
visualized by monitoring absorbance at 280 nm.
(TIF)
Figure S2 Substituting the hydrophobic domain of VP4
with transmembrane domain of leader peptidase abol-
ishes VP4 lytic activity. (A) GST-VP4, GST-VP4DHD, GST-
VP4HD/LepTM1 (LepTM1), and GST-VP4HD/LepTM2
(LepTM2) were incubated with bovine RBCs for 30 min at
37uC. Released hemoglobin was measured by the A414 of the
supernatant after centrifugation and the removal of unlysed cells.
GST was used as a control. (B) [S
35]-Met/Cys labeled VP4 binds
GST-VP4. Radiolabeled VP4 was synthesized with reticulocyte
lysate prior to GST-VP4 binding and isolation. VP4 was either
synthesized alone (lanes 4-6) or from the VP2 transcript that
supports the translation of VP2, VP3 and VP4 (lanes 1–3).
(TIF)
Text S1 The supporting text includes the supplemental materials
and methods as well as supplemental references.
(DOC)
Figure 7. VP4 forms small size selective pores in biological membranes. (A) Assessment of osmoprotection of red blood cells from lysis by
VP4. Bovine RBCs (0.5%, v/v) were mixed with GST-VP4 (10 mg/ml) in the presence of polyethylene glycols (PEGs) of increasing molecular weights (1.0,
4.0, 6.0, 8.0 and 10.0 kD). The error bars represent the standard deviation from three independent experiments. (B) Percentage LDH released from Cos
7 cells after incubation with VP4 and VP4DHD for 30 min at 37uC. The percentage of LDH released was calculated by dividing the LDH released from
samples by the LDH released with Triton X-100-permeabilized Cos 7 cells incubated under the same conditions (see Materials and Methods). The error
bars represent the standard deviation from three independent experiments each carried out in triplicate. (C) Assessment of osmoprotection of Cos 7
cells from lysis by GST-VP4. Cos 7 cells were mixed with GST-VP4 (10 mg/ml) in the presence of different molecular weights PEGs (1.0, 1.5, 2.0, 3.35, 4.0
and 6.0 kD). The error bars represent the standard deviation from three independent experiments performed in triplicate.
doi:10.1371/journal.ppat.1002116.g007
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